Clinical trials
Phase 4 Diabetes Mellitus trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 3 |
| Eli Lilly and Company | 2 |
| Hospital Universitario Pedro Ernesto | 2 |
| Hospital de Clinicas de Porto Alegre | 2 |
| Medtronic - MITG | 2 |
| University of Sao Paulo General Hospital | 2 |
| Beneficência Portuguesa de São Paulo | 1 |
| Centro de Diabetes Curitiba Ltda | 1 |
| Cristália Produtos Químicos Farmacêuticos Ltda. | 1 |
| Dr. José Fernando Vilela-Martin MD PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 24 |
| Diabetes Mellitus, Type 2 | 10 |
| Hypertension | 3 |
| Arrhythmias, Cardiac | 2 |
| Acute Kidney Injury | 1 |
| Bone Diseases, Metabolic | 1 |
| Coronary Artery Disease | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetic Neuropathies | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.